Covered recipient · General Payments record
EUNICE JEONGIN KIM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$298.44
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $215.79 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $198.05 | 19 |
| SCILEX PHARMACEUTICALS INC. | $17.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $10.97 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297216 | CMS |
| Amgen Inc. | $9.95 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297218 | CMS |
| Amgen Inc. | $9.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297220 | CMS |
| Amgen Inc. | $9.60 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297222 | CMS |
| Amgen Inc. | $10.87 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297224 | CMS |
| Amgen Inc. | $10.64 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297226 | CMS |
| Amgen Inc. | $10.29 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297228 | CMS |
| Amgen Inc. | $10.33 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297230 | CMS |
| Amgen Inc. | $10.58 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297232 | CMS |
| Amgen Inc. | $12.15 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297234 | CMS |
| Amgen Inc. | $10.83 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297236 | CMS |
| Amgen Inc. | $12.04 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297238 | CMS |
| Amgen Inc. | $11.11 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297240 | CMS |
| Amgen Inc. | $10.18 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297242 | CMS |
| Amgen Inc. | $11.69 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297244 | CMS |
| Amgen Inc. | $11.41 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297246 | CMS |
| Amgen Inc. | $9.40 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297248 | CMS |
| Amgen Inc. | $7.56 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297250 | CMS |
| Amgen Inc. | $9.45 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297252 | CMS |
| SCILEX PHARMACEUTICALS INC. | $17.74 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136266093 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.